Real World Baseline Characteristics and Early Patient Reported Outcomes in Adult Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab

Main Article Content

Peter Lio
Yestle Kim
Sanjeev Balu
Adriana Guana
Dawn Bates
deMauri Mackie
Halley Costantino
Amanda Lopez
Jennifer Soung


atopic dermatitis, tralokinumab


1. Bieber T. N Engl J Med. 2008;358(14):1483-1494.

2. Weidinger S, Novak N. Lancet. 2016;387(10023):1109-1122.

3. Kiebert G et al. Int J Dermatol. 2002;41(3):151-158.

4. Simpson EL, et al. Ann Allergy Asthma Immunol. 2022;129:592-604.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 > >>